April 6, 2020 – The Coalition for Healthcare Communication last week endorsed an urgent request to Maryland Governor Larry Hogan (R) to veto HB 732, which would put in place the nation’s first tax on digital advertising. The request, sent March 31 by national media and advertising trade associations and members of The Advertising Coalition, […]
Read more
March 25, 2019 – Several moves that could change the way prescription drug marketing and communications are conducted are being made in Washington, with the House Ways and Means Committee about to begin markup on a tax measure that could include eliminating the deductibility of drug marketing costs, and the Office of Management and Budget […]
Read more
Jan. 15, 2019 – In comments to the Centers for Medicare and Medicaid Services (CMS) regarding its proposal to require that drug companies include the wholesale acquisition cost (WAC) of a drug in direct-to-consumer (DTC) television ads, industry trade groups and pharmaceutical companies largely are in agreement that doing so would confuse consumers, that CMS […]
Read more
Dec. 4, 2017 – A new report from the National Academies of Science, Engineering and Medicine, “Making Medicines Affordable,” recommends promoting the adoption of industry codes of conduct, eliminating the tax deductibility of advertising expenses and discouraging direct-to-consumer (DTC) advertising in order to lower drug prices (http://bit.ly/2zX0jq7). “In yet another example of drug marketing being […]
Read more
Nov. 2, 2017 – In a memo sent to Coalition for Healthcare Communication members today, CHC Executive Director John Kamp reported that the Republican tax bill just announced “DOES NOT contain a provision to reduce the immediate deductibility of marketing costs, meaning we survived the first hurdle in this tax bill. Kamp told Coalition members […]
Read more
Sept. 18, 2017 – As pressure builds at the White House and among Republicans to pass some sort of tax reform, the Coalition for Healthcare Communication is mobilizing its members to express their support for “the full and immediate deductibility of all marketing costs, including those for medical marketing,” according to a memo sent to […]
Read more Jan. 13, 2017 – An amendment introduced by Sen. Al Franken (D-Minn.) to eliminate the tax deduction for drug marketing costs was not included in this week’s Senate voting on the repeal of the Affordable Care Act, thanks to immediate action by The Advertising Coalition (TAC), which focused on messages to all Senate offices that […]
Read moreMay 9, 2016 – In an April 29 comment to the FDA on its recent proposal to conduct research on how animation in direct-to-consumer (DTC) prescription drug advertising affects viewer comprehension, The Advertising Coalition (TAC) asks the agency to consider the Office of Prescription Drug Promotion’s mission statement “in the context of a series of […]
Read moreNov. 13, 2013 – The Advertising Coalition (TAC) is working to remove an advertising tax provision that reportedly is included in tax reform legislation being drafted by the House Ways and Means Committee. The provision would allow a business to deduct only 50 percent of advertising costs in the year the ad runs and would […]
Read moreApril 16, 2012 – The Coalition for Healthcare Communication (CHC) and The Advertising Coalition (TAC) recently told the FDA’s Office of Prescription Drug Promotion that a recent FDA study of “dual modality” risk disclosures does not support an FDA policy requiring both audio and text disclosures in all TV ads. “Although TV ads for drugs […]
Read more